<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Heparin-induced thrombocytopenia in the emergency department
2
Heparin-induced thrombocytopenia is rare in pregnancy
3
Heparin-induced thrombocytopenia with thrombotic sequelae: a review
4
Heparin-induced thrombocytopenia: an overview
5
Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery
6
Heparin-induced thrombocytopenia: clinical manifestations and management strategies
7
Heparinization of gas plasma-modified polystyrene surfaces and the interactions of these surfaces with proteins studied with surface plasmon resonance
8
Heparinized and Saline Solutions in the Maintenance of Arterial and Central Venous Catheters After Cardiac Surgery
9
Heparinized bovine pericardium as a novel cardiovascular bioprosthesis
10
Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance
11
Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane
12
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5
13
Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition
14
Heparinoid Anticoagulation and Topical Fibrin Sealant in Heparin-Induced Thrombocytopenia
15
Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum
16
Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum
17
Heparin–platelet factor 4 antibodies in patients presenting to the ED with thrombosis
18
Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF
19
Heparin-related thrombosis despite normal platelet counts in vascular surgery
20
Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis
21
Heparins in management of acute coronary syndromes without ST-segment elevation
22
Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts
23
Hepatectomy for liver metastases from breast cancer
24
Hepatectomy using traditional Péan clamp–crushing technique under intermittent Pringle maneuver
25
Hepatic “split lesion” in a fatal electrocution case
26
Hepatic “Stem” Cells: Coming Full Circle
27
Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability
28
Hepatic 5′-AMP-Activated Protein Kinase: Zonal Distribution and Relationship to Acetyl-CoA Carboxylase Activity in Varying Nutritional States
29
Hepatic 7-ethoxyresorufin O-deethylase Activity in eel (Anguilla Anguilla) from The Thames Estuary and Comparisons with other United Kingdom Estuaries
30
Hepatic abscess caused by Brucella US, CT and MRI findings: Case report and review of the literature
31
Hepatic activities of CYP1A and thiamine-dependent enzymes in Baltic salmon (Salmo salar) alevins suffering from the thiamine deficiency M74
32
Hepatic Acyl CoA Oxidase1 Inhibition Modifies Brain Lipids and Electrical Properties of Dentate Gyrus
33
Hepatic adenoma and focal nodular hyperplasia: mr findings with superparamagnetic iron oxide– enhanced mri
34
Hepatic adenomatosis: MRI demonstration with the use of superparamagnetic iron oxide
35
Hepatic allograft abscess with hepatic arterial thrombosis
36
Hepatic Alterations in the Amphibian Sclerophrys regularis as Biomarkers for Habitat Destruction
37
Hepatic alterations in the fish Rhamdia quelen contaminated with Folidol 600®
38
Hepatic Alveolar Echinococcosis
39
Hepatic alveolar echinococcosis: MRI findings
40
Hepatic Alveolar Hydatid Cyst: A Brief Review of Published Cases from Iran in the Last 20 Years
41
Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats
42
Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hypethyroid rats
43
Hepatic amino- to urea-N clearance and forearm amino-N exchange during hypoglycemic and euglycemic hyperinsulinemia in normal man
44
Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease
45
Hepatic and biliary biomarkers in rainbow trout injected with sediment extracts from the River Po (Italy)
46
Hepatic and extrahepatic dehydrogenation/isomerization of 5-cholestene-3β,7α-diol: localization of 3β-hydroxy-Δ5-C27-steroid dehydrogenase in pig tissues and subcellular fractions
47
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
48
Hepatic and Extra-hepatic Transcription of Inter-α-inhibitor Family Genes under Normal or Acute Inflammatory Conditions in Rat
49
Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins
50
Hepatic and Intestinal Schistosomiasis: Review
51
Hepatic and renal concentrations of 10 trace elements in crocodiles (Crocodylus niloticus) in the Kafue and Luangwa rivers in Zambia
52
Hepatic and renal concentrations of vitamins E and C in lead- and ethanol-exposed rats. An assessment of their involvement in the mechanisms of peroxidative damage
53
Hepatic and renal metallothionein induction by an oral equimolar dose of zinc, cadmium or mercury in mice
54
Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasis
55
Hepatic and splenic sarcoidosis as a cause of hypercalcemia: a case report
56
Hepatic angiomyolipoma with minimal fat content: MR demonstration
57
Hepatic Angiomyolipoma: a Rarely Described Tumor
58
Hepatic angiomyolipoma: Demonstration by out of phase MRI
59
Hepatic angiomyolipoma: Value of proton (fat/water) chemical shift fast low angle shot (FLASH) MR imaging technique in detecting fatty tissue content
60
HEPATIC ANGIOSARCOMA: REPORT OF A CASE WITHOUT A HISTORY OF EXPOSURE TO ENVIRONMENTAL RISK FACTORS
61
Hepatic antioxidant enzymes and total glutathione of Cyprinus carpio exposed to three disinfectants, chlorine dioxide, sodium hypochlorite and peracetic acid, for superficial water potabilization
62
HEPATIC ANTIOXIDANT, OXIDATIVE STRESS and HISTOPATHOLOGICAL CHANGES INDUCED BY NICOTINE IN A GENDER BASED STUDY IN ADULT RATS
63
Hepatic apolipoprotein and LDL receptor gene expression in the genetically hypercholesterolemic (RICO) rat Original Research Article
64
Hepatic Arterial Blood Flow Index Is Associated with the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection
65
Hepatic arterial blood flow velocities: assessment by transcutaneous and intravascular Doppler sonography
66
Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma
67
Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview
68
Hepatic Arterial Infusion Chemotherapy with Cisplatin for TACE-Refractory or -Ineligible Hepatocellular Carcinoma with Child-Pugh Score of 8 or Above
69
Hepatic arterial infusion for hepatic metastases from Colon Cancer
70
Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi
71
Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi
72
Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure
73
Hepatic Artery and Portal Vein Doppler Indexes in Non‑alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs
74
Hepatic Artery Aneurysms as a Rare but Important Cause of Abdominal Pain; a Case Series
75
Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors
76
Hepatic artery chemotherapy and colorectal liver metastases
77
Hepatic artery chemotherapy and colorectal liver metastases
78
Hepatic artery chemotherapy and colorectal liver metastases
79
Hepatic artery chemotherapy and colorectal liver metastases
80
Hepatic artery embolisation with a novel radiopaque polymer causes extended liver necrosis in pigs due to occlusion of the concomitant portal vein
81
Hepatic artery infusion for liver metastases from colorectal cancer
82
Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation
83
Hepatic artery ligation: a simple and safe technique to treat extrahepatic aneurysms of the hepatic artery
84
Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development
85
Hepatic Artery Pseudoaneurysm ; Simple or Difficult to Diagnose
86
Hepatic artery pseudoaneurysm; a rare complication of Amoebic liver abscess
87
Hepatic Basolateral Plasma High-affinity Ca2+-RATPase is Inhibited by Nitric Oxide and Peroxynitrite Anion
88
Hepatic bile salt flux does not modulate level and activity of the sinusoidal Na+-taurocholate cotransporter (ntcp) in rats
89
Hepatic binding proteins translocating azo dye carcinogen metabolites from cytoplasm into nucleus in rats
90
Hepatic biomarkers of sediment-associated pollution in juvenile turbot, Scophthalmus maximus L.
91
Hepatic biomarkers of xenobiotic metabolism in eighteen marine fish from NW Mediterranean shelf and slope waters in relation to some of their biological and ecological variables
92
Hepatic biotransformation of alkylresorcinols is mediated via cytochrome P450 and β-oxidation: A proof of concept study
93
Hepatic bisegmentectomy 7–8 for a colorectal metastasis
94
Hepatic blood flow and splanchnic oxygen consumption in patients with hepatic encephalopathy before and after high-volume plasmapheresis
95
Hepatic blood flow responses to mechanical stimulation of the skin in anaesthetised rats
96
Hepatic branch vagotomy can block liver regeneration enhanced by ursodesoxycholic acid in 66% hepatectomized rats
97
HEPATIC CAPILLARIASIS IN CHILDREN: REPORT OF 3 CASES IN BRAZIL
98
Hepatic cavernous hemangiomas: Patterns of contrast enhancement on MR fluoroscopy imaging
99
Hepatic cell-specific ATP-binding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice
100
Hepatic cellular and tissue pathologic response in the mosquito fish, Gambusia affinis, to different time exposure of diethylnitrosamine
101
Hepatic Changes in the Freeze-Tolerant Turtle Chrysemys picta marginata in Response to Freezing and Thawing
102
Hepatic Choristoma: an Unexpected Finding During Cholecystectomy
103
Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?
104
Hepatic CYP1A in winter flounder (Pleuronectes americanus) along the Northeast Coast: Results from the national benthic surveillance project
105
Hepatic CYP1A levels and EROD activity in English sole: biomonitoring of marine contaminants in Vancouver Harbour
106
Hepatic CYP450 gene expression, hematological and biochemical indices in Caspian roach (Rutilus caspius) induced by Endosulfan
107
Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia
108
Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase
109
Hepatic cytochrome P4501A and 7-ethoxyresorufin O-deethylase induction in mullet and common sole as an indicator of toxic organic pollution in Izmir Bay, Turkey
110
Hepatic differentiation of porcine induced pluripotent stem cells in vitro
111
Hepatic DNA adducts and production of mutagenic urine in 2,6-dinitrotoluene-treated B6C3F, male mice
112
Hepatic duct diverticulum
113
Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation
114
Hepatic dysfunction associated with atenolol
115
Hepatic Dysfunction in Ambulatory Patients With Heart Failure: Application of the MELD Scoring System for Outcome Prediction
116
Hepatic dysfunction in critically ill patients
117
Hepatic Effects of Endothelin: Metabolism of [125I]Endothelin-1 by Liver-Derived Cells
118
Hepatic elemental contents and antioxidant enzyme activities in Algerian mice (Mus spretus) inhabiting a mine area in central Portugal
119
Hepatic encephalopathy and ascites
120
Hepatic encephalopathy and ascites
121
Hepatic encephalopathy and nitric oxide
122
Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?
123
Hepatic Encephalopathy Linked to COVID-19 in a Pediatric Case: A Rare Presentation of COVID-19
124
Hepatic encephalopathy: Clinical aspects and pathogenetic concept
125
Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis
126
Hepatic Energy and Substrate Metabolism: A Possible Metabolic Basis for Early Nutritional Support in Cirrhotic Patients
127
Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response
128
Hepatic Epithelioid Hemangioendothelioma: A Review of Three Liver Transplant Recipients
129
Hepatic EROD Activity in Flounder (Platichthys flesus) as an Indicator of Contaminant Exposure in English Estuaries
130
Hepatic ethoxyresorufin O-deethylase (EROD) activity in flounder (Platichthys flesus) from contaminant impacted estuaries of the United Kingdom: continued monitoring 1999–2001
131
Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases
132
Hepatic expression of regeneration marker genes following partial hepatectomy in the rat : Influence of 1,25-dihydroxyvitamin D3 in hypocalcemia
133
Hepatic expression profiling in smolting and adult coho salmon (Onchorhynchus kisutch)
134
Hepatic Failure After Bariatric Surgery: A Systematic Review
135
Hepatic Failure in a Young Woman Following Ingestion of Tribulus Terrestris
136
Hepatic Failure Related to Itraconazole Use Successfully Treated by Corticosteroids
137
Hepatic fatty acid metabolism in rats fed diets with different contents of C18 : 0, C18 : 1 cis and C18 : 1 trans isomers
138
Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids
139
Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways
140
Hepatic fructose-metabolizing enzymes and related metabolites: role of dietary copper and gender
141
Hepatic functional reserve in patients with obstructive jaundice: An assessment by the redox tolerance test
142
Hepatic gene expression and lipid parameters in complement C3−/− mice that do not develop ethanol-induced steatosis
143
Hepatic gene expression and plasma albumin concentration related to outcome after attenuation of a congenital portosystemic shunt in dogs
144
Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients
145
Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice
146
Hepatic gene expression profile in brown trout (Salmo trutta) exposed to traffic related contaminants Original Research Article
147
Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes
148
Hepatic gene induction in murine bone marrow after hepatectomy
149
Hepatic glucose metabolism in humans—its role in health and disease
150
Hepatic glucose output response to nicotine and the underlying neural mechanism in rats
151
Hepatic Glutamate Dehydrogenase Activity and the Presence of Ammonia and Urea in the Circulatory Fluid of Channa Gachua in WaterRestricted Condition
152
Hepatic glutaminase—a special role in urea synthesis?
153
Hepatic glutamine metabolism
154
Hepatic glutamine metabolism during endotoxemia in neonatal rats
155
Hepatic glutathione in English sole (Pleuronectes vetulus): Response to complex mixtures of xenobiotics
156
Hepatic glutathione S-transferase activity in flounder collected from contaminated and reference sites along the Polish coast
157
Hepatic glutathione S-transferases from lamprey (Petromyzom marinus): purification and characterization
158
Hepatic granuloma mimicking recurrent lymphoma on ^18F-FDG PET/CT in a patient with primary mediastinal diffuse large B-cell lymphoma
159
Hepatic granulomas associated with brucellosis
160
Hepatic Health and Humoral Immunological Parameters of Common Carp (Cyprinus carpio) Fed Lactic Acid-supplemented Diets
161
Hepatic hemosiderosis in buffalo fish (Ictiobus spp.)
162
Hepatic histology in obese patients undergoing bariatric surgery
163
Hepatic histopathology in two populations of the mummichog, Fundulus heteroclitus
164
Hepatic hyaline globules in an Eclectus parrot (Eclectus roratus)
165
Hepatic hydatid cyst presenting as a cutaneous fistula
166
HEPATIC HYDROTHORAX WITH MODERATE ASCITIS IN A NIGERIAN
167
Hepatic hydrothorax: pathogenesis, diagnosis, and management
168
Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), ,
169
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection
170
Hepatic Impact of Different Concentrations of Hibiscus rosa Zinc Oxide Nanoparticles on Rats
171
Hepatic inflammatory mass secondary to toothpick perforation of the stomach: triphasic CT appearances
172
Hepatic injury and vitamin A ingestion
173
Hepatic Involvement and Association with Prognosis in COVID-19 Patients: A Single-Centre Report from Iran
174
Hepatic Involvement in Dengue Fever in Children
175
Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C
176
Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del “loss of function” mutations in ferroportin disease
177
Hepatic iron metabolism gene expression profiles in HFE associated Hereditary Hemochromatosis
178
Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study.
179
Hepatic iron overload and hepatocellular carcinoma
180
Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis?
181
Hepatic iron status and response to therapy in chronic viral hepatitis B and C: A preliminary report
182
Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts
183
Hepatic ischemia secondary to hepatic artery ligation: MRI findings
184
Hepatic Ischemia/Reperfusion Injury Is Diminished by Atorvastatin in Wistar Rats
185
Hepatic ischemia-reperfusion injury
186
Hepatic ischemia-reperfusion injury
187
Hepatic levels of metal and metallothioneins in two commercial fish species of the Northern Iberian shelf
188
Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture Original Research Article
189
Hepatic lipase mediates lipoprotein uptake into cells via LDL receptor-related protein
190
Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study
191
Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor
192
Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study
193
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice
194
Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model
195
Hepatic lipidosis in a common Mynah (Acridotheres tristis) associated with pododermatitis and consumption of broiler pelleted feed
196
Hepatic lipogenic enzyme expression in pigs is affected by selection for decreased backfat thickness at constant intramuscular fat content
197
Hepatic Lobectomy-Case Report of Two Patients, Performed at Chittagong Medical College Hospital
198
Hepatic localisation of rat cysteine dioxygenase
199
Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality
200
Hepatic metabolism of sulfur amino acids in db/db mice
201
Hepatic metabolism, phase I and II biotransformation enzymes in Atlantic salmon (Salmo Salar, L) during a 12 week feeding period with graded levels of the synthetic antioxidant, ethoxyquin
202
Hepatic metallothionein as a biomarker for metal contamination: age effects and seasonal variation in European flounders (Pleuronectes flesus) from the Severn Estuary and Bristol Channel
203
Hepatic metallothionein concentrations in the golden grey mullet (Liza aurata) – Relationship with environmental metal concentrations in a metal-contaminated coastal system in Portugal
204
Hepatic metastasis complicated by abscess formation
205
Hepatic Microcirculatory Changes Induced by Hepatic Artery Embolization in Rats Original Investigation
206
Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats
207
Hepatic mitochondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells
208
Hepatic mono-oxygenase induction in benthic flatfish sampled near coastal pulp mills in British Columbia
209
Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C
210
Hepatic multi-nodular focal fatty metamorphosis in acquired porphyria cutanea tarda: Sonographic, CT, and mri features
211
Hepatic mycotic aneurysms
212
Hepatic myelopathy Case report with review of the literature
213
Hepatic myelopathy with spastic paraparesis
214
Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase
215
Hepatic Necrosis: A Main Presentation of Systemic Lupus Erythematosus in a Previously Healthy Woman
216
Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease
217
Hepatic Osteodystrophy: a relationship between osteoporotic bone and chronic liver disease
218
Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man
219
Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo
220
Hepatic overlap syndromes
221
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage
222
Hepatic Oxidative Damages and Glucose Tolerance in Diabetic Rats Exposed to Repeated Oral Doses of Diazinon
223
Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients
224
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis
225
Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis chronic hepatitis
226
Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy
227
Hepatic portal venous gas
228
Hepatic portal venous gas: clinical significance of computed tomography findings
229
Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects
230
Hepatic protection by perioperative metabolic support?
231
Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model
232
Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients
233
Hepatic pseudocapillarisation and atherosclerosis in ageing
234
Hepatic radiofrequency ablation using perfusion electrodes in a pig model: Effect of the Pringle manoeuvre
235
Hepatic reduction of insulin-like growth factor (IGF)-I and IGF binding protein-3 that results from fasting is not attenuated in genetically obese rats
236
Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice
237
Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients, , , ,
238
Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat
239
Hepatic resection for hepatocellular carcinoma
240
Hepatic resection for hepatocellular carcinoma in Taiwan
241
Hepatic resection for large hepatocellular carcinoma
242
Hepatic resection for malignant melanoma
243
Hepatic resection for metastatic neuroendocrine carcinomas
244
Hepatic resection for recurrent metastatic ovarian cancer
245
Hepatic resection in breast cancer metastases: should it be considered standard treatment?
246
Hepatic resection in metastatic breast cancer: results and prognostic factors
247
Hepatic resection using stapling devices
248
Hepatic resection with vascular isolation and routine supraceliac aortic clamping
249
Hepatic retractor in an ex vivo model
250
Hepatic Rupture After Heimlich Maneuver
251
Hepatic Sarcodosis presenting as portal hypertension in a young boy
252
Hepatic sarcoidosis: MR appearances in patients with chronic liver disease
253
Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article
254
Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats
255
Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids
256
Hepatic Steatosis
257
Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway
258
Hepatic Steatosis among Obese Children and Adolescents
259
Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening
260
Hepatic steatosis and insulin resistance: Does etiology make a difference?
261
Hepatic Steatosis and Related Factors in Obese Children Attending National Nutritional Institute
262
Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E
263
Hepatic steatosis in chronic hepatitis B and C: Predictors, distribution and effect on fibrosis
264
Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study
265
Hepatic Steatosis in Iranian Patients with Chronic Hepatitis C
266
Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men
267
Hepatic steatosis: An experimental model for quantification
268
Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte
269
Hepatic stellate cell activation in genetic haemochromatosis : Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
270
Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis
271
Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis
272
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers
273
Hepatic stellate cells (Ito-cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat
274
Hepatic stellate cells and the regulation of liver inflammation
275
Hepatic stellate cells are an important cellular site for β-carotene conversion to retinoid
276
Hepatic stellate cells become susceptible to fas-ligand induced apoptosis during transformation to myofibroblasts
277
Hepatic stellate cells do not derive from the neural crest
278
Hepatic stellate cells in human schistosomiasis mansoni: A comparative immunohistochemical study with liver cirrhosis
279
HEPATIC STELLATE CELLS IN THE CONTEXT OF LIVER FIBROSIS
280
Hepatic stem cells
281
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
282
Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model
283
Hepatic tissue damage induced in Meriones ungliculatus due to infection with Babesia divergens-infected erythrocytes
284
Hepatic Tissue Engineering Using Scaffolds: State of the Art
285
Hepatic Toxocariasis in a Child: ACase Report from Shiraz, Southern Iran
286
Hepatic triacylglycerols and serum non-esterified fatty acids (NEFA) variations in indigenous water buffalo (Bubalus bubalis) in the province of Khuzestan, Iran
287
Hepatic tumor necrosis factors production and distant organ dysfunction in a murine model of obstructive jaundice
288
Hepatic tumours in childhood: An experience at the Children Hospital and Institute of Child Health, Lahore
289
Hepatic undifferentiated embryonal sarcoma: malignant evolution of mesenchymal hamartoma? Study of one case with immunohistochemical and flow cytometric emphasis
290
Hepatic vagotomy inhibits proliferation of hepatic stellate cells in rats with acute hepatitis
291
Hepatic vascular calcification: An early second trimester sonographic feature of idiopathic infantile arterial calcinosis
292
Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family
293
Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae
294
Hepatic vein velocities in children with right ventricular hypertension
295
Hepatic vein waveform in liver cirrhosis: Correlation with Child’s class and size of varices
296
Hepatic veno-occlusive disease with immunodeficiency (VODI): First reported case in the U.S. and identification of a unique mutation in Sp110
297
Hepatic Venous Malformation After Modified Fontan Procedure With Partial Hepatic Vein Exclusion
298
Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy
299
Hepatic viral infections in Yemen between 2000-2005
300
Hepatic von Meyenburg complex simulating biliary cystadenocarcinoma
301
Hepatic, Renal and Cardiovascular Biomarker Variability in Type 2 Diabetes Mellitus Patients with Poor Glycemic Control
302
Hepaticocholecystoduodenostomy compared with Roux-en-y choledochojejunostomy for decompression of the biliary tract
303
Hepatiti C and Ocular urface Dieae Original Reearch Article
304
Hepatitis A 2004 Vaccination in Children: Methods and Findings of a Survey in Two States Original Research Article
305
Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases
306
Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus
307
Hepatitis A and E: not to be forgotten
308
Hepatitis A and vigorous physical activity
309
Hepatitis A booster vaccination: is there a need?
310
Hepatitis A Chronic Immunity in Iran: A Geographic Information System-Based Study
311
Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran
312
Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography
313
HEPATITIS A IN LATIN AMERICA: A CHANGING EPIDEMIOLOGIC PATTERN
314
Hepatitis A in the Eastern Mediterranean Region: A Review on the Prevalence
315
Hepatitis A Infection Presented with Pancytopenia, a Case Series in Children
316
Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report
317
Hepatitis A linked to clotting factors in USA
318
Hepatitis A Prevention Strategies, Haiti Case: Should Rescuers Be Immunized
319
Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran
320
Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study
321
Hepatitis a seroprevalence among young adults: Effects of ACIP immunization recommendations
322
Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran
323
Hepatitis A Vaccination among Thai Medical Students: A Questionnaire Study
324
Hepatitis A vaccine failure
325
Hepatitis A vaccine for Israeli children
326
Hepatitis A vaccine for secondary hepatitis A infection
327
Hepatitis A vaccine for secondary hepatitis A infection
328
Hepatitis A vaccine for secondary hepatitis A infection
329
Hepatitis A vaccine for secondary hepatitis A infection
330
Hepatitis A vaccine for secondary hepatitis A infection
331
Hepatitis A vaccine in the last-minute traveler
332
Hepatitis A virus – a general overview
333
Hepatitis A Virus and Coronary Artery Diseases
334
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
335
Hepatitis A virus in environmental water samples from the Amazon Basin
336
Hepatitis A Virus Infection
337
Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV
338
Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers
339
Hepatitis A virus infection: Is it an important hazard to public health?
340
Hepatitis A Virus Seropositivity in Nurses and Paramedical Personnel at a University Hospital in North Iran
341
Hepatitis A virus vaccination in Iranian soldiers needs more attention
342
Hepatitis A Virus: Is Vaccination Necessary in Middle East?
343
Hepatitis A Virus: Seroepidemiological Study in Fars Province
344
Hepatitis A with Pleural Effusion, Ascites and Acalculous Cholecystitis
345
Hepatitis after intravenous buprenorphine misuse in heroin addicts
346
Hepatitis agent cloned and designated hepatitis G virus
347
Hepatitis and community: The current scenario and a roadmap for 2030
348
Hepatitis and death following vaccination with 17D-204 yellow fever vaccine
349
Hepatitis and HIV screening, education, and treatment for adults with serious mental illness
350
Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections
351
Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles
352
Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors
353
Hepatitis B and C among thalassemiac patients in Iran: A multicenter study
354
Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors
355
Hepatitis B and C and the Role of Non-specialists on Disease Elimination
356
Hepatitis B and C in HIV-infected patients : Prevalence and prognostic value
357
Hepatitis B and C infection in first-time blood donors in Karachi – a possible subgroup for sentinel surveillance
358
Hepatitis B and C Infections Among Pediatric Patients with Sickle Cell Disease at a Tertiary Hospital in Nigeria
359
Hepatitis B and C Infections and Different Genotypes of HCV Among Sickle Cell Anemia Patients in Ahvaz, South-Western Iran
360
Hepatitis B and C Infections in Hamadan Province during 2004-2009
361
Hepatitis B and C knowledge among Saudi dental patients
362
Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt
363
Hepatitis B and C Viral Infection: Prevalence, Knowledge, Attitude, Practice, and Occupational Exposure among Healthcare Workers of Jimma University Medical Center, Southwest Ethiopia
364
Hepatitis B and C viral infections in chronic liver disease: a populationbased study in Qatar
365
Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges
366
Hepatitis B and C virus infection and the risk of atherosclerosis in a general population
367
Hepatitis B and C: An alarming situation in Southern part of Khyber Pakhtunkhwa, Pakistan
368
Hepatitis B and C: Prevention is better than cure
369
Hepatitis B and health-care workers
370
Hepatitis B and health-care workers
371
Hepatitis B and health-care workers
372
Hepatitis B and health-care workers
373
Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran
374
Hepatitis B and Hepatitis C Seroprevalence in the Center of Sanliurfa Province From Southeastern Anatolia Region and Related Risk Factors
375
Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: A survey by serologic and molecular methods
376
Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences
377
Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda
378
Hepatitis B and its Relationship With Oxidative Stress
379
Hepatitis B associated liver failure following bone marrow transplantation
380
Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia
381
Hepatitis B Birth Dose among Children in District 2 Hospital, Ho Chi Minh City, Vietnam: Prevalence and Associated Factors
382
Hepatitis B booster vaccination for healthcare workers
383
Hepatitis B Core Antibody ImmunoglobulinMin Blood Donors With a History of Hepatitis B Virus Infection
384
HEPATITIS B e ANTIGEN AND THE RISK OF HEPATOCELLULAR CARCINOMA
385
Hepatitis B e Antigen-Negative Chronic Hepatitis B
386
Hepatitis B envelope protein mutants
387
Hepatitis B epidemiology and cultural practices in Amerindian populations of Amazonia: The Tupí-Mondé and the Xavánte from Brazil
388
Hepatitis B genotypes and the response to interferon therapy
389
Hepatitis B Genotypes in Iran
390
Hepatitis B genotypes in patients with acute hepatitis B virus infection
391
Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
392
Hepatitis B immunisation in chronically transfused recipients
393
Hepatitis B immunisation in Singapore
394
Hepatitis B Immunization in Health Care Workers: Needs and Opportunities
395
Hepatitis B immunization in postpartum women
396
Hepatitis B in a high prevalence New Zealand population: A mathematical model applied to infection control policy
397
Hepatitis B in China
398
Hepatitis B infection among Asian American Pacific Islanders in the Rocky Mountain area
399
Hepatitis B Infection among Korean Americans in Colorado: Evidence of the Need for Serologic Testing and Vaccination
400
Hepatitis B infection among Nigerian children admitted to a children’s emergency room
401
Hepatitis B Infection among Patients Receiving Chronic Hemodialysis at the Royal Medical Services in Jordan
402
Hepatitis B Infection during Renal Replacement Therapy
403
Hepatitis B infection in Eastern Indian families: Need for screening of adult siblings and mothers of adult index cases
404
Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward
405
Hepatitis B Infection in Hemodialysis Patients in Tehran Province, Iran
406
Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey
407
Hepatitis B infection: Pathogenesis and management
408
Hepatitis B Infection: Prevalence and Response to Vaccination among Health Care Workers in Babol, Northern Iran
409
Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province
410
Hepatitis B Knowledge Among Healthy Volunteers in Duhok City, Kurdistan Region, Iraq
411
Hepatitis B Knowledge Among Iranian Adolescents: A National Survey
412
Hepatitis B or hepatitis C and human immunodeficiency virus infection
413
Hepatitis B pregenomic RNA splicing—The products, the regulatory mechanisms and its biological significance
414
Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure
415
Hepatitis B Prevention Education and Afghan Immigrant Students
416
Hepatitis B reactivation after lamivudine
417
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
418
Hepatitis B Recurrence After Liver Transplantation: A Single Center Experiences and Review the Literature
419
Hepatitis B resistance in Iran
420
Hepatitis B Seroconversion Rate After Primary Immunization Series with Newly Introduced Pentavalent Vaccine: A Report of Local Study in Alborz Province, Iran, 2016
421
Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand
422
Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013
423
Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014
424
Hepatitis B Splice-Generated Protein Antibodies in Syrian Chronic Hepatitis B Patients: Incidence and Significance
425
Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago
426
Hepatitis B surface antibody purification with hepatitis B surface antibody imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-l-tyrosine methyl ester) particles
427
Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine
428
Hepatitis B Surface Antigen and Viral DNA Detection and Prevalence in Nigeria
429
Hepatitis B surface antigen carrier rate in unvaccinated and vaccinated children with thalassaemia major at Bahawal Victoria Hospital, Bahawalpur, Pakistan
430
HEPATITIS B SURFACE ANTIGEN DISAPPEARANCE AND HEPATITIS B SURFACE ANTIGEN SUBTYPE: A PROSPECTIVE, LONG-TERM, FOLLOW-UP STUDY OF JAPANESE RESIDENTS OF OKINAWA, JAPAN WITH CHRONIC HEPATITIS B VIRUS INFECTION
431
Hepatitis B Surface Antigen Prevalence among Pregnant Women in Rafsanjan City, Iran, 2003
432
Hepatitis B surface antigen prevalence in pregnant women: A cross‑sectional survey in Iran
433
Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria
434
Hepatitis B Surface Antigen, Hepatitis C Virus Antibody, Body Mass Index, and Alcohol Drinking among Workers with Elevated Serum Alanine Aminotransferase
435
Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria
436
Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh
437
Hepatitis B testing among Vietnamese American men
438
Hepatitis B transmission from contaminated cryopreservation tank
439
Hepatitis B vaccination after liver transplantation as a strategy to discontinue prophylaxis with hepatitis B immune globulin
440
Hepatitis B vaccination among primary health care workers in Northwest Pakistan
441
HEPATITIS B VACCINATION AND INFANTILE IDIOPATHIC THROMBOCYTOPENIC PURPURA
442
Hepatitis B vaccination coverage among Iranian children aged 15–26 months in 2006
443
Hepatitis B Vaccination Coverage Among Iranian Medical Students and Nursing Staff
444
Hepatitis B Vaccination Coverage and Its Associated Factors in Nurses of Imam Reza (AS) Hospital in Kermanshah
445
Hepatitis B Vaccination Coverage and Sharp Injuries Among Healthcare Workers in Hamadan, Iran
446
Hepatitis B vaccination coverage in medical students at a medical college of Mirpurkhas
447
Hepatitis B Vaccination Coverage, HBS-Ab Level and its Related Factors among Dentistry and Medical Students
448
Hepatitis B Vaccination Efficacy in Iranian Healthcare Workers: A Meta-Analysis Study
449
Hepatitis B vaccination follow-up
450
Hepatitis B Vaccination in Bangladesh: a Suggestion Based on Current Evidence
451
Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients
452
Hepatitis B vaccination in correctional health care workers
453
Hepatitis B vaccination in correctional health care workers
454
Hepatitis B vaccination of babies in Melanesia
455
Hepatitis B vaccination of health care workers in Saudi Arabia
456
Hepatitis B vaccination program at a New York City hospital: Seroprevalence, seroconversion, and declination, ,
457
Hepatitis B Vaccination Reliability in Celiac Disease
458
Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact
459
Hepatitis B vaccination strategy for newborn babies
460
Hepatitis B Vaccination: Needs a Revision
461
Hepatitis B vaccination: to boost or not to boost?
462
Hepatitis B Vaccine Acceptability among Nurses: A Theory Based Conceptualization
463
Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
464
Hepatitis B vaccine booster dose: Low-dose recombinant hepatitis B vaccines as a booster dose,
465
Hepatitis B vaccine boosting among young healthy adults
466
Hepatitis B vaccine boosting: the debate continues
467
Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana’a, Yemen
468
Hepatitis B vaccine in patients on haemodialysis
469
Hepatitis B vaccine, hepatitis C virus infection, and haemodialysis
470
Hepatitis B Vaccine: Immunity, Efficacy and Types.
471
Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors
472
Hepatitis B viral genotypes and lamivudine resistance
473
Hepatitis B Viral Markers in Surface Antigen Negative Blood Donors: The Need to Look Beyond Antibody Negativity
474
Hepatitis B viral resistance: mechanisms and diagnosis
475
Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling
476
Hepatitis B Virus (HBV) and Occult Hepatitis B Virus (OBI) in Hemodialysis Patients: An Epidemiological Observational Study in Kerman, Iran (2022-2023)
477
Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics
478
Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria
479
Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China
480
Hepatitis B Virus / Human Immunodeficiency Virus Co-Infection and Its Hepatocarcinogenic Potential in Sub-Saharan Black Africans
481
Hepatitis B virus among maintainence haemodialysis patients: A report from Karachi, Pakistan
482
Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: Impact of hepatitis B vaccine
483
Hepatitis B virus and celiac disease
484
Hepatitis B Virus and Cytomegalovirus Infections Disrupt Sperm Parameters in Males through Decreasing Mitochondrial Membrane Potential: A Case-control Study
485
Hepatitis B virus and hepatocellular carcinoma
486
Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda
487
Hepatitis B virus and host factors
488
Hepatitis B Virus and Malaria Co-infection Causing Significant Changes in Hematological and Liver Function Indices in a Cohort of Subjects in Ilorin, Nigeria
489
Hepatitis B Virus Antibody Levels in High-Risk Health Care Workers
490
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor
491
Hepatitis B Virus Complications of Pregnancy After Kidney Transplantation
492
Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania
493
Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C
494
Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies
495
Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran
496
Hepatitis B virus DNA level as predictor of response to therapy with interferon-alpha-2b (PDferon) in chronic hepatitis B infection
497
Hepatitis B virus E antigen but not HBV core is presented to specific CD4+ T cells via the endogenous antigen processing pathway
498
Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro
499
Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors
500
Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression
501
Hepatitis B virus genetic diversity in Latin America
502
Hepatitis B virus genetic variability and evolution
503
Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma
504
Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection
505
Hepatitis B Virus Genotype G Infection in a Turkish Patient Undergoing Hemodialysis Therapy
506
Hepatitis B virus genotypes and extrahepatic manifestations
507
Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014
508
Hepatitis B Virus Genotypes in Eastern Azerbaijan, Northwest Iran
509
Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region
510
Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy
511
Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran
512
Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran
513
Hepatitis B virus Genotyping Among Patients With Cirrhosis
514
Hepatitis B Virus Immunity Status and Booster Dose Efficacy in Health Sciences Students: An Interventional Study
515
Hepatitis B virus in cervicovaginal lavage samples of pregnant women in Gorgan city, north of Iran
516
Hepatitis B virus induced hepatocellular carcinoma
517
Hepatitis B Virus Infection among Health Colleges’ Students in Aseer Region, Southwestern Saudi Arabia
518
Hepatitis B virus infection among staff in three hospitals in Khartoum, Sudan, 2006–07
519
Hepatitis B Virus Infection and Exposure Among Foreign-Born Asian Americans in the U.S.
520
Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran
521
Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran
522
Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma
523
Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention
524
Hepatitis B Virus Infection Flare Induced Acute-on-chronic Liver Failure After COVID-19 Vaccination: A Case Report
525
HEPATITIS B VIRUS INFECTION IN AN ANTI-HBC NEGATIVE PATIENT: A CASE REPORT
526
Hepatitis B virus infection in Iran
527
Hepatitis B Virus Infection in Iran: A Systematic Review
528
Hepatitis B Virus Infection in Iran: Current Knowledge, Future Plans
529
Hepatitis B Virus Infection in Iranian Hemodialysis Patients A Systematic Review and Meta-Analysis
530
Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers
531
Hepatitis B Virus Infection in Patients with Blood Disorders: A Concise Review in Pediatric S
532
Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis
533
Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient?
534
Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran
535
Hepatitis B virus infection without immunological markers after open-heart surgery
536
Hepatitis B virus infection: Current status
537
Hepatitis B Virus Infection; A Vanishing Disease in Iranian Children
538
Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis
539
Hepatitis B virus large surface protein: function and fame
540
Hepatitis B virus mutants and efficacy of vaccination
541
Hepatitis B virus mutants and efficacy of vaccination
542
Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation
543
Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma
544
Hepatitis B Virus PreS Variant and Hepatocellular Carcinoma
545
Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter
546
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response
547
Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research
548
Hepatitis B virus replication and viral antigen synthesis in hepatocyte lines derived from normal human liver
549
Hepatitis B virus resistance to antivirals: clinical implications and management
550
Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy
551
Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis
552
Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese
553
Hepatitis B Virus Should not be Forget in Health Care Worker
554
Hepatitis B virus subtypes and lamivudine resistance
555
Hepatitis B Virus Surface Antigen (HBsAg) Mutations Are Rare but Clustered in Immune Epitopes in Chronic Carriers from Sistan-Balouchestan Province, Iran
556
Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran
557
Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma
558
Hepatitis B Virus Vaccination in Hemodialysis Patients: A Necessity for Individualizing of Immunization?
559
Hepatitis B Virus Vaccine immune response in Egyptian children 15-17 years after primary immunization; should we provide a booster dose?
560
Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase
561
Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish
562
Hepatitis B virus X gene is implicated in liver carcinogenesis
563
Hepatitis B virus X mediates podocyte pyroptosis by regulating the ROS/NLRP3 signaling pathway in hepatitis B virus-associated glomerulonephritis
564
Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response
565
Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection
566
Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression
567
Hepatitis B virus X protein interacts with NF-KB inhibitors
568
Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16INK4a expression via DNA methylation
569
Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3
570
Hepatitis B virus X protein stimulates the Hedgehog–Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells
571
Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells
572
Hepatitis B virus YMDD-motif mutations with emergence of lamivudine-resistant mutants: a threat to recovery
573
Hepatitis B Virus, Hepatitis C Virus Markers and Serum Alanine Amino-Transferase (ALT) Levels, in a Young Adult Population of Sylhet District
574
Hepatitis B Virus-associated Glomerulonephritis
575
Hepatitis B Virus-associated Nephropathy An International Data Analysis
576
Hepatitis B viruses and cancerogenesis
577
Hepatitis B viruses: Reverse transcription a different way
578
Hepatitis B virus-induced hepatocellular carcinoma
579
Hepatitis B virus-infected cells can be eliminated by the cytotoxic T cell-mediated immune reaction. Fas ligand, recently detected on the surface of cytotoxic T cell, is thought to induce cells to apoptosis by adhering to Fas antigen. Aims/Methods: To eva
580
Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination
581
Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran
582
Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey
583
Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Seropositivity Among Children in Kabul, Afghanistan: A Cross-Sectional Study
584
Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon
585
Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015
586
Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015
587
Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey*
588
Hepatitis B: Epidemiology and prevalence in Iran, during 2002-2014
589
Hepatitis B: Knowledge, Vaccine Situation and Seroconversion of Dentistry Students of a Public University
590
Hepatitis B: Reflections on the current approach to antiviral therapy
591
Hepatitis BMarkers in Isfahan, Central Iran: APopulation-Based Study
592
Hepatitis B-Related Concerns and Anxieties Among People With Chronic Hepatitis B in Australia
593
Hepatitis C (HCV) Viremic Rate and its Correlation to Demographic Factors among HCV Confirmed Iranian Blood Donors
594
Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features
595
Hepatitis C among Hemodialysis Patients: Impact of Strict Adherence to Universal Precautions
596
Hepatitis C among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors
597
HEPATITIS C AMONG YOUNG MALE OFFENDERS ADMITTED TO THE CENTRAL JAIL, LAHORE
598
Hepatitis C and alcohol
599
Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage
600
Hepatitis C and B-cell non-Hodgkin’s lymphoma: a geographicallyvariable association?
601
Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda
602
Hepatitis C and Depression
603
Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran
604
Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran
605
Hepatitis C and Hepatitis B Virus Infection: Epidemiology and Risk Factors in a Large Cohort of Pregnant Women in Lorestan, West of Iran
606
Hepatitis C and HIV infection: biological, clinical, and therapeutic implications
607
Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems
608
Hepatitis C and liver transplantation
609
Hepatitis C and pulmonary fibrosis
610
Hepatitis C and renal failure
611
Hepatitis C and Steatosis
612
Hepatitis C and Teens
613
Hepatitis C and Teens
614
Hepatitis C and the correctional population
615
Hepatitis C and the heart: to beat or not to beat
616
Hepatitis C and thyroid autoimmunity: is there a link?
617
Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013
618
Hepatitis C at work place: A survey of Occupational Health and Safety Knowledge and Practice in Beauty Therapy Industry
619
Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era
620
Hepatitis C detection
621
Hepatitis C detection
622
Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre
623
Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
624
Hepatitis C Genotypes in Hemophilia Patients in Iran
625
Hepatitis C Genotypes in Hemophilia Patients in Iran
626
Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma
627
HEPATITIS C IN A COMMUNITY IN UPPER EGYPT: I. CROSS-SECTIONAL SURVEY
628
Hepatitis C in Australia: Impact of a Mass Media Campaign Original Research Article
629
Hepatitis C in haemophilia patients in the Netherlands
630
Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)
631
Hepatitis C in hemodialysis patients needs more attention for control and review the risk factors
632
Hepatitis C in Iran. How Extensive of a Problem Is It?
633
Hepatitis C in Pakistan: A Review of Available Data
634
HEPATITIS C IN PERU: RISK FACTORS FOR INFECTION, POTENTIAL IATROGENIC TRANSMISSION, AND GENOTYPE DISTRIBUTION
635
Hepatitis C in State Correctional Facilities
636
Hepatitis C in the Eastern Mediterranean Region
637
Hepatitis C in the patient with human immunodeficiency virus infection
638
Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan
639
Hepatitis C infection and autoimmune hemolytic anemia in a patient with colon B-cell non-hodgkin lymphoma: a case report
640
Hepatitis C infection and polymyositis
641
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
642
Hepatitis C infection from anti-D immunoglobulin
643
Hepatitis C Infection in Egyptian Psoriatic Patients: Prevalence and Correlation with Severity of Disease
644
Hepatitis C infection in Iran; A review article
645
Hepatitis C Infection in the General Population of Iran: A Systematic Review
646
Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients
647
Hepatitis C infection is characterized by a high incidence of liver cirrhosis, frequently requiring liver transplantation. After orthotopic liver transplantation, recurrence of hepatitis C virus infection is common, but often difficult to differentiate fr
648
Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting
649
Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting
650
Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function
651
Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse
652
Hepatitis C NS3 helicase unwinds RNA in leaps and bounds
653
Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure
654
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives
655
Hepatitis C outbreak astounds Spain
656
Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population
657
Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population
658
Hepatitis C Rapid Point-of-Care Testing and Laboratory-based Non-invasive Assessment of Liver Fibrosis among Drug Abusers: An Experience from Iran
659
Hepatitis C seropositivity in patients with acute and chronic urticaria
660
Hepatitis C seroprevalence among intravenous drug users in Tehran
661
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system
662
Hepatitis C therapy in treatment-naïve patients
663
Hepatitis C transmission associated with intravenous immunoglobulins
664
Hepatitis C transmission by cosmetic tattooing in women
665
Hepatitis C Treatment Among People Who Use Drugs in an Office-Based Opioid Treatment Program Versus a Syringe Exchange Program: A Real-World Prospective Clinical Trial
666
Hepatitis C treatment update
667
Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan
668
Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules
669
Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin
670
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy
671
Hepatitis C viral life cycle
672
Hepatitis C virus
673
Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents
674
Hepatitis C Virus (HCV) “A Possible Independent Risk Factor” for Coronary Artery Disease
675
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells
676
Hepatitis C virus (HCV) genotype 1B infection is associated with a high incidence of graft cirrhosis after liver transplantation (OLT)
677
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
678
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection
679
Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan
680
Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction
681
Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital
682
Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection
683
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia
684
Hepatitis C virus (HCV)-infection and oral lichen planus
685
Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
686
Hepatitis C virus and blood transfusion: past and present risks
687
Hepatitis C virus and hepatocellular carcinoma
688
Hepatitis c virus and human immunodeficiency virus: clinical issues in coinfection
689
Hepatitis C Virus and Human Immunodeficiency Virus-I (HIV) Co-Infection in Children in Benin City, Nigeria.
690
Hepatitis C virus and kidney disease
691
Hepatitis C Virus and Lichen Planus: The Real Association
692
Hepatitis C virus and liver steatosis: when fat is not beautiful
693
Hepatitis C Virus and Vaccine Development
694
Hepatitis C Virus Antibodies and Vitiligo Disease
695
Hepatitis C Virus Antibody Positive Cases in Multitransfused Thalassemic Patients in South of Iran
696
Hepatitis C virus antibody, viral RNA and genotypes in leprous patients in Japan
697
Hepatitis C Virus as a Multifaceted Disease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection
698
Hepatitis C virus assembly: When fat makes it easier
699
Hepatitis C Virus Capsid Protein and Intracellular Lipids Interplay and Its Association With Hepatic Steatosis
700
Hepatitis C virus challenges AIDS associated viruses at the transfusion crossings: the place and time for a second trial
701
Hepatitis C virus clearance improves quality of life
702
Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin
703
Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals
704
Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b
705
Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression
706
Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes
707
Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
708
Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation
709
Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation
710
Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2
711
Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation
712
Hepatitis C Virus Core Protein: An Update on Its Molecular Biology, Cellular Functions and Clinical Implications
713
Hepatitis C Virus Cryoglobulinemia and non-Hodgkin Lymphoma
714
Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients
715
Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein
716
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
717
Hepatitis C virus genetic variability in patients undergoing antiviral therapy
718
Hepatitis C virus genotype 1 associated with massive steatosis of the liver and hypo-β-lipoproteinemia
719
Hepatitis C Virus Genotype Distribution in Shiraz, Southern Iran
720
Hepatitis C Virus Genotypes and Association With Viral Load in Yazd, Central Province of Iran
721
Hepatitis C virus genotypes and quasispecies
722
Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia
723
HEPATITIS C VIRUS GENOTYPES IN A NORTHEASTERN AREA OF BRAZIL
724
Hepatitis C virus genotypes in Adana and Antakya regions of Turkey
725
HEPATITIS C VIRUS GENOTYPES IN BAHAWALPUR
726
Hepatitis C virus genotypes in elderly patients with chronic hepatitis C
727
HEPATITIS C VIRUS GENOTYPES IN IRAQ
728
Hepatitis C Virus Genotypes in Patients Referred to Educational Hospitals in Zahedan (2009 ‒ 2013)
729
Hepatitis C virus Genotypes in Patients with End-Stage Renal Disease in East Azerbaijan, Iran
730
Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples
731
Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azerbaijan, Northwest of Iran
732
Hepatitis C virus in blood donation
733
Hepatitis C virus in breast milk
734
Hepatitis C virus in elderly patients with chronic liver diseases
735
HEPATITIS C VIRUS IN IRAN: EPIDEMIOLOGY OF AN EMERGING INFECTION
736
Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes
737
Hepatitis C Virus in North Africa: An Emerging Threat
738
Hepatitis C virus in people with HIV infection
739
Hepatitis C virus in people with HIV infection
740
Hepatitis C virus in saliva of haemophiliac patients attending an oral surgery unit
741
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
742
Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy
743
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk
744
Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran
745
Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt
746
Hepatitis C virus infection among patients on hemodialysis: A report from a single center in Iran
747
Hepatitis C Virus Infection among Teaching Hospital Patients in Kano, Nigeria: A Retrospective Study
748
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town
749
Hepatitis C virus infection and autoimmune thrombocytopenic purpura
750
Hepatitis C Virus Infection and Chronic Obstructive Pulmonary Disease
751
Hepatitis C virus infection and cryoglobulinemia
752
Hepatitis C virus infection and genotypes in blood donors
753
Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
754
Hepatitis C Virus Infection and Kidney Transplantation A Review for Clinicians
755
Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France
756
Hepatitis C virus infection and primary Sjögrenʹs Syndrome: A clinical and serologic description of 9 patients
757
Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt
758
Hepatitis C Virus Infection Complicated by Kidney Disease
759
Hepatitis C Virus Infection in Blood Donors: An Emerging Risk to Transfusion Services
760
Hepatitis C virus infection in children
761
Hepatitis C virus infection in dialysis centers of Tabriz, Iran: a multicenter study
762
Hepatitis C virus infection in dialysis patients
763
Hepatitis C virus infection in Eastern Europe
764
Hepatitis C virus infection in hemodialysis patients in Sudan: Two centers report
765
Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures
766
Hepatitis C Virus Infection in Isfahan, Iran: A Review Article
767
Hepatitis C virus infection in nephrology patients
768
Hepatitis C Virus Infection in Non-Hodgkin’s Lymphoma: A Case-ControlStudy
769
HEPATITIS C VIRUS INFECTION IN PATIENTS ON LONG TERM HEMODIALYSIS
770
Hepatitis C Virus Infection in Patients with Hemophilia in Isfahan, Iran
771
Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication
772
Hepatitis C virus infection in special groups
773
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis
774
Hepatitis C virus infection in the United States
775
Hepatitis C virus infection in Western Europe
776
Hepatitis C virus infection manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis
777
Hepatitis C virus infection of salivary gland epithelial cells : Lack of evidence
778
Hepatitis C Virus Infection Trends in Italy
779
Hepatitis C Virus Infection Trends in Italy, 1996–2006
780
Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction
781
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?
782
Hepatitis C virus infection, tuberculosis, and sexually transmitted diseases
783
Hepatitis C virus infection: co-infection with HIV and HBV
784
Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in I.R. IRAN
785
Hepatitis C virus infection: quality of life and side effects of treatment
786
Hepatitis C virus infection: when silence is deception
787
Hepatitis C virus infection-associated non-cryoglobulinaemic monoclonal IgMκ gammopathy responsive to interferon-α treatment
788
Hepatitis C Virus Load in Seropositive Liver and Kidney Transplant Recipients by Quantitative Real-Time PCR Before and After Transplantation
789
Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture
790
Hepatitis C virus NS3 NTPase/Helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step
791
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety Original Research Article
792
Hepatitis C Virus NS3 Protease Requires Its NS4A Cofactor Peptide for Optimal Binding of a Boronic Acid Inhibitor as Shown by NMR Original Research Article
793
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding
794
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of moiety with improved potency
795
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034
796
Hepatitis C virus NS3-4A serine protease inhibitors: Use of a P2–P1 cyclopropyl alanine combination for improved potency
797
Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death
798
Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt
799
Hepatitis C Virus RNA (HCV-RNA) in Blood Donors and Family Members Seropositive for Anti-HCV Antibodies
800
Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L
801
Hepatitis C virus RNAs replicating in cell culture
802
Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department
803
Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity
804
Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran
805
Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine
806
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
807
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
808
Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA
809
Hepatitis C virus transmission by intravenous immunoglobulin
810
Hepatitis C virus transmission by monoclonal- purified viral-attenuated factor VIII concentrate
811
Hepatitis C Virus Treatment Revolution: Eastern European Story
812
Hepatitis C Virus Treatment with Sofosbuvir Plus Ribavirin Regimen in Khuzestan Province
813
Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes
814
Hepatitis C virus ultrastructure and morphogenesis.
815
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients
816
Hepatitis C virus, rheumatoid factors, and disease progression
817
Hepatitis C virus, Sjögrenʹs syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer
818
Hepatitis C Virus. Current Studies in Hematology and Blood Transfusion : Edited by Harvey Reesink, 212, S. Karger AG, Basel, DM 290, ISBN 3-8055-5866-X
819
Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, November 2011, Tehran, Iran
820
Hepatitis C Virus; Its Implication for Endodontists
821
Hepatitis C virus-related arthritis
822
Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C
823
Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy
824
Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level in Healthy, Anti-HCV-Negative Individuals
825
Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women
826
Hepatitis C with and without dermatological manifestations: comparison of human leukocyte antigen-DR types, circulating T-cell subsets, and relation to disease severity
827
Hepatitis C, ,
828
Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions
829
Hepatitis C. Biomedical Research Reports: T. Jake Liang and Jay H. Hoofnagle (Eds.), Academic Press, 2000, ISBN 0-12-447870-0, $99.95
830
HEPATITIS C: A COMMON BUT INFREQUENTLY TREATED DISEASE
831
HEPATITIS C: A LEADING CAUSE OF CIRRHOSIS AT DHQ HOSPITAL D.I.KHAN
832
Hepatitis C: molecular virology and antiviral targets
833
Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia
834
Hepatitis C: public health strategies
835
Hepatitis C: the clinical spectrum of the disease
836
Hepatitis C: the dermatologic profile
837
Hepatitis C-Associated Chronic Lymphoproliferative Disorders: A Single Center Experience
838
Hepatitis C-Associated Osteosclerosis After Blood Transfusion
839
Hepatitis C-Associated Osteosclerosis: An Unusual Syndrome of Acquired Osteosclerosis in Adults
840
Hepatitis C—virology and future antiviral targets
841
Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin
842
Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme levels and Histopathology-an Epidemiological Study in Shiraz, Southern Iran, 2003-2004
843
Hepatitis D Is a Forgotten Problem in Hemodialysis Patients in the World
844
Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in “Isolated anti-HBc” Antibodies Profile in Central Tunisia
845
Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
846
Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections
847
Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia)
848
Hepatitis disease diagnosis using a new hybrid system based on feature selection (FS) and artificial immune recognition system with fuzzy resource allocation
849
Hepatitis DVirus Infection among HIV-HBV Co-Infected Patients in Kermanshah, West of Iran
850
Hepatitis E antibodies and HIV status
851
Hepatitis E associated with surgical training on pigs
852
Hepatitis E in Brazil
853
HEPATITIS E SEROCONVERSION IN UNITED STATES TRAVELERS ABROAD
854
Hepatitis E Virus
855
Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death
856
Hepatitis E virus and HIV infection in homosexual men
857
Hepatitis E virus and pigs: A zoonotic risk in Europe?
858
Hepatitis E Virus and Renal Transplantation
859
Hepatitis E virus and serum level aminotransferases in blood donors
860
Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis
861
Hepatitis E virus genotyping based on full-length genome and partial genomic regions
862
Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants
863
Hepatitis E virus infection
864
Hepatitis E Virus Infection Among Chronic Hemodialysis
865
Hepatitis E Virus Infection Among Iranian Patients with Beta-Thalassemia
866
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis
867
Hepatitis E Virus Infection in a Northern Mexican City: A Cross-Sectional Seroprevalence Study
868
Hepatitis E Virus Infection in Hemodialysis Patients: A Seroepidemiological Survey in Jahrom, Southern Iran
869
Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients
870
Hepatitis E Virus Infection in Macaca Mulatta
871
Hepatitis E Virus Infection: A Neglected Problem in Our Region
872
Hepatitis E virus load in swine organs and tissues at slaughterhouse determined by real-time RT-PCR
873
Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran
874
Hepatitis E Virus Seroprevalence Among Liver Transplant Recipients with Persistent Elevation of Liver Enzymes: A Single Center Report
875
Hepatitis E Virus Seroprevalence and Viremia in Hemodialysis and HIV Infected Patients in Iran
876
Hepatitis E virus seroprevalence in haemodialysis patients in Zanjan province, Islamic Republic of Iran
877
Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran
878
Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate
879
Hepatitis E: a virus in waiting
880
Hepatitis E: An emerging awareness of an old disease
881
Hepatitis E: Risk and Prevention
882
Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection
883
Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection
884
Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan‑Iran
885
Hepatitis G virus in immunosuppressed paediatric allograft recipients
886
Hepatitis G virus in India
887
Hepatitis G virus in Karachi, Pakistan
888
Hepatitis G virus in long-term survivors of haematological malignancy
889
Hepatitis G virus infection
890
Hepatitis G virus infection
891
Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy
892
Hepatitis G Virus Infection in Iranian Blood Donors and High-Risk Groups
893
Hepatitis G-associated aplastic anaemia
894
Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany
895
Hepatitis in Ontario linked to EEG electrodes
896
Hepatitis induced by Kava (Piper methysticum rhizoma)
897
Hepatitis meeting suggests end of “carrier” status
898
Hepatitis Monthly, an International Journal in the Field of Hepatology
899
Hepatitis patients lost to follow-up at a liver centre in a tertiary care hospital of Karachi, Pakistan — a cross-sectional descriptive study
900
Hepatitis treatment in developing countries
901
Hepatitis treatment moves on
902
Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma
903
Hepatitis virus infection and atherosclerosis: reply to Vassalle, Zucchelli and Giustini
904
Hepatitis Virus Infection and Hodgkin s Lymphoma: A Review of the Literature
905
Hepatitis virus infections in heart transplant recipients
906
Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment
907
Hepatitis viruses and the MAPK pathway: is this a survival strategy?
908
Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes
909
Hepatitis viruses in the XXI century
910
Hepatitis: A Rapidly Spreading Viral Infection in Pakistan
911
Hepatitis-B vaccine down under
912
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
913
Hepatitis-C and Hepatitis-B Co-Infections in Patients with Human Immunodeficiency Virus in Tehran, Iran
914
Hepatitis-C Infection Incidence Among the non-Hodgkin’s B-cell Lymphoma Patients in the Northeast of Iran
915
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
916
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
917
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
918
Hepatitis-C-virus risk from Italian fertility centre
919
Hepatitis-E-associated fulminant hepatic failure in non-pregnant young women
920
Hepato- and Reno-Protective Impacts of Plantago major: An Experimental Model of Testicular Ischemia/Reperfusion
921
Hepato Protective and Antioxidant Role of Berberis tinctoria Lesch Leaves on Paracetamol Induced Hepatic Damage in Rats
922
Hepatoadrenal syndrome in Egyptian children with liver cirrhosis with and without sepsis
923
Hepatoatrial anastomosis and tricuspid valve replacement in budd-chiari syndrome 8.
924
Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis
925
Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
926
Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen
927
Hepatobiliary Cystadenoma Mimicking Liver Hydatid Cyst
928
Hepatobiliary Cystadenoma with Mesenchymal Stroma Mistaken for Common Bile Duct Stone
929
Hepatobiliary excretion and brain distribution of caffeine in rats using microdialysis Original Research Article
930
Hepatobiliary excretion of 99mTc-EC: A potential source of mistake in the interpretation of renal scintigraphy
931
Hepatobiliary Excretion of Dipyrrinone Sulfonates in Mrp2-Deficient (TR−) Rats
932
Hepatobiliary Fascioliasis: Clinical and Radiological Features
933
Hepatobiliary Involvement in Neonates With COVID-19 Infection: A Narrative Review
934
Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride
935
Hepatobiliary scintigraphy: An effective tool in the management of bile leak following laparoscopic cholecystectomy
936
Hepatobiliary surgeons meet immunologists: the case of colorectal liver metastases patients
937
Hepatobiliary surgery
938
HepatoBiliary Surgery and Nutrition - Message from the Editor-in-Chief
939
Hepatobiliary Surgery and Nutrition is indexed by SCIE: a tremendous step forward
940
Hepatobiliary surgery: the past, present, and future learned from Professor Henri Bismuth
941
Hepatobiliary transport
942
Hepatobiliary, renal and bone complications of intestinal failure
943
Hepatoblastoma in a 2-year-old child of a liver-transplanted mother
944
Hepatoblastoma in a patient with a partial trisomy 9p syndrome: a case report
945
Hepatoblastoma Related Tumor Thrombosis Extended to IVC, Ra and Pulmonary Artery Branches: A Case Report
946
Hepatoblastomas in Oman
947
Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
948
Hepatocarcinogenesis: A polygenic model of inherited predisposition to cancer
949
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
950
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
951
Hepatocellular adenoma displaying a HNF1α inactivation in a patient with familial adenomatous polyposis coli
952
Hepatocellular adenomas in patients taking danazol for here ditary angiooedema
953
Hepatocellular Cancer: A Guide for the Internist
954
Hepatocellular carcinoma
955
Hepatocellular carcinoma
956
Hepatocellular carcinoma
957
Hepatocellular carcinoma
958
Hepatocellular carcinoma
959
Hepatocellular carcinoma
960
Hepatocellular carcinoma
961
Hepatocellular carcinoma
962
Hepatocellular carcinoma (HCC) recurrence and what to do when it happens
963
Hepatocellular carcinoma after radiofrequency ablation therapy: Dynamic CT evaluation of treatment
964
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol
965
Hepatocellular Carcinoma and Academic Skills Workshop cosponsored by Hepatobiliary Surgery and Nutrition and AME Publishing Company
966
Hepatocellular carcinoma and extrahepatic primary malignancy
967
Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran
968
Hepatocellular carcinoma and the art of prognostication
969
Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?
970
Hepatocellular carcinoma development in cirrhosis
971
Hepatocellular Carcinoma Diagnosis Based on Ultrasound Images Using Feature Selection Techniques and K-nearest Neighbor Classifier
972
Hepatocellular carcinoma from diagnosis to treatment: 15 years of challenges and modification of resection strategies
973
Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report
974
Hepatocellular Carcinoma in a non-B non-C Non-alcoholic Steatohepatitis (NBNC-NASH HCC)
975
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal α-fetoprotein
976
Hepatocellular carcinoma in a young survivor of major burns
977
Hepatocellular carcinoma in alcoholics
978
Hepatocellular Carcinoma in Dog – Case Report
979
HEPATOCELLULAR CARCINOMA IN EGYPTIANS WITH AND WITHOUT A HISTORY OF HEPATITIS B VIRUS INFECTION: ASSOCIATION WITH HEPATITIS C VIRUS (HCV) INFECTION BUT NOT WITH HCV RNA LEVEL
980
Hepatocellular Carcinoma in Explanted Livers of Patients with Genotype D HBV Cirrhosis: Report of the First Experience from Iran
981
Hepatocellular Carcinoma in Pakistan: Where do We Stand?
982
Hepatocellular carcinoma in patients suffering from primary sclerosing cholangitis
983
Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors
984
Hepatocellular carcinoma in patients with HCV
985
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
986
Hepatocellular Carcinoma in Port Harcourt, Nigeria: Clinicopathologic Study of 75 Cases
987
Hepatocellular Carcinoma in Pregnancy with Unusual Presentations
988
Hepatocellular Carcinoma in Sheep.
989
Hepatocellular Carcinoma in Sheep.
990
Hepatocellular carcinoma in situs inversus totalis-a case report
991
Hepatocellular Carcinoma in the World and the Middle East
992
Hepatocellular Carcinoma in Two Patients with Autoimmune Hepatitis, A Single Center Experience and Review of the Literature
993
Hepatocellular Carcinoma is an Emerging Issue Now in Iran
994
Hepatocellular carcinoma markers in the omics era: the glycomic analysis
995
Hepatocellular carcinoma on the increase in USA
996
Hepatocellular carcinoma with disseminated skeletal muscle metastasis
997
Hepatocellular carcinoma with extension into the right atrium
998
Hepatocellular Carcinoma With Intracavitary Cardiac Involvement: A Case Report and Review of the Literature
999
Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation
1000
Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM
